Magle Chemoswed Holding AB (publ) (STO:MAGLE)

Market Cap	7.87M -98.1%
Revenue (ttm)	275.79M -3.4%
Net Income	-261.78M
EPS	-12.72
Shares Out	30.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	174,059
Open	0.2780
Previous Close	0.2800
Day's Range	0.2000 - 0.2780
52-Week Range	0.1200 - 21.2000
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 2, 2026

About STO:MAGLE

Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies; and contract development and manufacturing organization activitie...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1944
• Employees: 150
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MAGLE

Financial Performance

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 9, 2026

Data Sources Report a data error